Tag: nasdaq:aeri

September 19, 2019

Aerie Pharma Seeks FDA Nod to Sell Ireland-based Product in US

If the FDA grants Aerie Pharma approval, it will be able to manufacture Rocklatan in Ireland for sale in the...
August 15, 2018

Aerie Pharmaceuticals Reports Topline Result from Rhopressa Mechanism of Action Study

Aerie Pharmaceuticals (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment...
August 1, 2018

Aerie Pharmaceuticals and DSM Biomedical Expand Collaboration Agreement

Aerie Pharmaceuticals (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment...